RNA Therapeutics: Reshaping the Future of Precision Medicine

RNA therapeutics are a rapidly growing class of medicines that use RNA molecules to regulate, replace, or correct biological processes. Unlike traditional small-molecule drugs that mainly target proteins, RNA-based approaches can directly control gene expression, offering new ways to treat previously difficult-to-target diseases.

Major types of RNA therapeutics

1. mRNA therapeutics

• Deliver messenger RNA to cells to produce a desired protein.
• Best known from mRNA COVID-19 vaccines.
• Expanding into:
  • cancer vaccines
  • protein replacement therapies
  • regenerative medicine

2. siRNA (small interfering RNA) therapeutics

• Use RNA interference (RNAi) to selectively silence specific genes.
• siRNA guides the Argonaute 2 protein complex to degrade target mRNA.
• Applications include reducing disease-causing proteins in:
  • genetic disorders
  • liver diseases
  • cardiovascular diseases

3. Antisense oligonucleotides (ASOs)

• Short synthetic RNA/DNA-like molecules that bind target RNA and alter its stability or processing.
• Used for diseases caused by abnormal gene expression or splicing defects.

4. microRNA-based therapeutics

• Mimic or inhibit natural regulatory RNAs that control many genes.
• Being explored in cancer and fibrosis.

Key challenges

Despite great potential, RNA therapeutics face several engineering challenges:

• Delivery: Getting RNA molecules into the correct tissues and cells.
• Stability: Protecting RNA from degradation.
• Immune activation: Avoiding unwanted inflammatory responses.
• Specificity: Minimizing off-target effects.

Technologies such as Lipid nanoparticles, chemical RNA modifications, and improved targeting molecules are helping overcome these barriers.